Skip to main content
A WORLDWIDE ALLERGY COMPANY
A WORLDWIDE ALLERGY COMPANY
Find your location
  • Global
    •
  • Australia
    •
  • Austria
    •
  • Belgium
    •
  • Canada
    •
  • Czech republic
    •
  • France
    •
  • Germany
    •
  • Italy
    •
  • Netherlands
    •
  • Middle East
    •
  • New Zealand
    •
  • Nordics
    •
  • Poland
    •
  • Russia
    •
  • Slovakia
    •
  • Spain
    •
  • Switzerland
    •
  • United Kingdom
    •
  • USA
    •
  • ABOUT
    • Our business
    • Global footprint
    • Strategy
      • Board of Directors
      • Executive committee
      • Compliance, Ethics, Transparency
      Governance
    • History
  • IMPACT
    • Corporate responsibility
    • Foundation
  • ALLERGIES
    • About allergies
    • Respiratory allergies
    • Food allergy
    • Veterinary allergies
    • Allergens
  • SOLUTIONS
    • Diagnosis
    • Patient journey
    • Treatment
    • Portfolio
  • SCIENCE
    • Precision medicine
    • Clinical Development
    • Manufacturing
    • Partnering
  • NEWS CENTER
    • Press releases
    • Publications
    • 2023 Company Report
  • CAREERS
    • Our culture
    • Testimonials
    • Explore job opportunities
  • ABOUT
    • Our business
    • Global footprint
    • Strategy
    • Governance
      • Board of Directors
      • Executive committee
      • Compliance, Ethics, Transparency
    • History
  • IMPACT
    • Corporate responsibility
    • Foundation
  • ALLERGIES
    • About allergies
    • Respiratory allergies
    • Food allergy
    • Veterinary allergies
    • Allergens
  • SOLUTIONS
    • Diagnosis
    • Patient journey
    • Treatment
    • Portfolio
  • SCIENCE
    • Precision medicine
    • Clinical Development
    • Manufacturing
    • Partnering
  • NEWS CENTER
    • Press releases
    • Publications
    • 2023 Company Report
  • CAREERS
    • Our culture
    • Testimonials
    • Explore job opportunities
Find your location
  • Global
    •
  • Australia
    •
  • Austria
    •
  • Belgium
    •
  • Canada
    •
  • Czech republic
    •
  • France
    •
  • Germany
    •
  • Italy
    •
  • Netherlands
    •
  • Middle East
    •
  • New Zealand
    •
  • Nordics
    •
  • Poland
    •
  • Russia
    •
  • Slovakia
    •
  • Spain
    •
  • Switzerland
    •
  • United Kingdom
    •
  • USA
    •

Breadcrumb

  1. News center
  2. Press releases
News center

Breadcrumb

  1. News center
  2. Press releases
News center
  • Press releases
  • Publications
  • 2023 Company Report
News center

Press releases

For matters related to Global communications, please contact:

Catherine Kress 

Head of Communications

Email: communications@stallergenesgreer.com

Tel:  +33 (0)1 55 59 26 05

Subscribe

Browse by year

  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025

2010-11-02 - Stallergenes welcomes Ares Life Sciences as a new reference shareholder

Download

2010-10-14 - Significant growth for Stallergenes

Download

2010-09-06 - STALLERGENES AND SHIONOGI SIGN EXCLUSIVE PARTNERSHIP AGREEMENTS FOR IMMUNOT...

Download

2010-08-26 - First half-year 2010 results

Download

2010-06-28 - Persistent efficacy demonstrated after a year on Actair® followed by a 2nd ...

Download

2010-06-21 - Staloral® mites 300 clinical study in China: the efficacy of sublingual imm...

Download

2010-05-19 - Positive results for Oralair® phase III trial in the USA

Download

2010-05-15 - Q1 2010 Sales

Download

2010-03-16 - 2009 Annual results

Download

2010-01-14 - Strong sales growth in Q4 2009: up 15%

Download
  • Press releases
  • Publications
  • 2023 Company Report
© 2025 Stallergenes Greer
    |
  • Site Map
    • |
  • terms & conditions
    • |
  • Modern Slavery Act Statement
    • |
  • Contact
  • Cookie Policy
    • |
  • Personal Data Protection Policy

YOU ARE LEAVING THE STALLERGENESGREER.COM WEBSITE

This link will take you to content that may not be appropriate for UK audiences on a website to which our Privacy Policy does not apply. Stallergenes Greer UK has no control over the contents of these sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them.

Continue

Cookies

Reject and continue

STALLERGENES GREER uses technical cookies essential for the functioning of the site as well as audience measurement cookies. You can accept audience measurement cookies by clicking on “Accept” or reject them by clicking on “Reject and continue”. You can change your mind at any time by clicking on “Cookies Management” and manage your preferences by clicking on “Set your preferences”. For more information, please read our Cookie Policy

Set your preferences

Google Analytics
Track website traffic
Save my preferences
Set your preferences
Accept Save my preferences
Cookies Management